Tools
Tools
Brandt, SD, Kavanagh, PV, Westphal, F, Stratford, A, Odland, AU, Klein, AK, Dowling, G, Dempster, NM, Wallach, J, Passie, T and Halberstadt, AL (2020) Return of the lysergamides. Part VI: Analytical and behavioural characterization of 1-cyclopropanoyl-d-lysergic acid diethylamide (1CP-LSD). Drug Testing and Analysis, 12 (6). pp. 812-826. ISSN 1942-7603
|
Text
DTA-20-0053.R1_accepted_uncorrected.pdf - Accepted Version Download (2MB) | Preview |
|
|
Text
Supporting Information – Drug Testing and Analysis.pdf - Supplemental Material Download (14MB) | Preview |
Abstract
Lysergic acid diethylamide (LSD) is a prototypical serotonergic psychedelic drug and the subject of many clinical investigations. In recent years, a range of lysergamides has emerged with the production of some being inspired by the existing scientific literature. Others, for example various 1-acyl substituted lysergamides, did not exist before their appearance as research chemicals. 1-Cylopropanoyl-LSD (1CP-LSD) has recently emerged as a new addition to the group of lysergamide-based designer drugs and is believed to be psychoactive in humans. In this investigation, 1CP-LSD was subjected to detailed analytical characterizations including various mass spectrometry (MS) platforms, gas and liquid chromatography, nuclear magnetic resonance spectroscopy, solid phase and GC condensed phase infrared spectroscopy. Analysis by GC-MS also revealed the detection of artificially induced degradation products. Incubation of 1CP-LSD with human serum led to the formation of LSD, indicating that it may act as a prodrug for LSD in vivo, similar to other 1-acyl substituted lysergamides. The analysis of blotters and pellets is also included. 1CP-LSD also induces the head-twitch response (HTR) in C57BL/6J mice, indicating that it produces an LSD-like behavioural profile. 1CP-LSD induced the HTR with an ED50 = 430.0 nmol/kg which was comparable with 1P-LSD (ED50 = 349.6 nmol/kg) investigated previously. Clinical studies are required to determine the potency and profile of effects produced by 1CP-LSD in humans.
| Item Type: | Article |
|---|---|
| Additional Information: | This is the peer reviewed version of the following article:Brandt, SD, Kavanagh, PV, Westphal, F, et al. Return of the lysergamides. Part VI: Analytical and behavioural characterization of 1-cyclopropanoyl-d-lysergic acid diethylamide (1CP-LSD). Drug Test Anal. 2020; 12: 812– 826 which has been published in final form at https://doi.org/10.1002/dta.2789. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. |
| Uncontrolled Keywords: | 0301 Analytical Chemistry, 1115 Pharmacology and Pharmaceutical Sciences |
| Subjects: | R Medicine > RM Therapeutics. Pharmacology |
| Divisions: | Pharmacy & Biomolecular Sciences |
| Publisher: | Wiley |
| Date Deposited: | 13 Mar 2020 09:51 |
| Last Modified: | 29 Nov 2021 10:30 |
| URI: | https://researchonline.ljmu.ac.uk/id/eprint/12478 |
 |
View Item |